Psychiatric News - Risk-Benefit Analyses in Medication Decision Making (Joseph Goldberg, MD)

New York, NY
 – May 17, 2013  –– 

For both patients and practitioners, adverse drug effects—whether actual or imagined—are high on the list of reasons for avoiding psychotropic medications. While the adage may ring true that the cure shouldn’t be worse than the disease, optimal treatments often demand a careful assessment of the balance between risks and benefits. This equation becomes fairly simple when many well-tolerated treatments exist for nonlethal or nondisabling ailments; or conversely, when the morbidity and mortality of a disorder are so obvious as to overshadow concerns about possible treatment complications.
-Dr. Joseph F. Goldberg, Clinical Professor, Psychiatry, Icahn School of Medicine at Mount Sinai
Learn more